<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04947449</url>
  </required_header>
  <id_info>
    <org_study_id>STU-2021-0241</org_study_id>
    <nct_id>NCT04947449</nct_id>
  </id_info>
  <brief_title>Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors</brief_title>
  <official_title>Laser Therapy on Burned Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine effects of laser therapy on blood flow and sweating&#xD;
      responses in burn-injured skin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a longitudinal study in which the effects of laser therapy on cutaneous vascular&#xD;
      responses and sweating of the treated areas are assessed. Specifically, burn survivors who&#xD;
      will undergo standard of care laser therapy to treat burn-related scars will perform&#xD;
      whole-body heating and local heating procedures prior to the initiation of laser therapy, at&#xD;
      an intermediate point during the laser therapy regimen, and upon conclusion of the laser&#xD;
      therapy regimen.&#xD;
&#xD;
      For this pilot investigation a placebo will not be incorporated.&#xD;
&#xD;
      Primary outcome variables will be skin blood flow and sweating responses from skin treated&#xD;
      with laser therapy and adjacent untreated/uninjured skin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 29, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Skin blood flow</measure>
    <time_frame>Upwards to 6 months after the final laser treatment</time_frame>
    <description>Primary outcome variables will be skin blood flow and sweating responses from skin treated with laser therapy and adjacent untreated/uninjured skin.</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Burn Injury</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fractional CO2 laser</intervention_name>
    <description>Standard of care laser treatment of burn-related injuries will be performed. This protocol assesses the effects of those treatments on skin blood flow and sweating responses.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy individuals who undergo laser treatment for burn injuries&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-65 years old&#xD;
&#xD;
          -  Experience a severe burn injury that warrant laser therapy.&#xD;
&#xD;
          -  Free of any significant underlying medical problems based upon a detailed medical&#xD;
             history and physical exam&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known heart disease&#xD;
&#xD;
          -  Other chronic medical conditions requiring regular medical therapy including cancer,&#xD;
             diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia.&#xD;
&#xD;
          -  Abnormality detected on routine screening suggestive of cardiac ischemia or previously&#xD;
             undetected cardiac disease or resting left bundle branch block on screening&#xD;
             electrocardiogram.&#xD;
&#xD;
          -  Subject with a body mass index &gt;35 kg/m2&#xD;
&#xD;
          -  Pregnant or planning to become pregnant within the subsequent 6 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Josh Foster, PhD</last_name>
    <phone>214-345-6504</phone>
    <email>joshfoster@texashealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bonnie Orth, MS</last_name>
    <phone>214-345-4737</phone>
    <email>bonnieorth@texashealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Crandall, PhD</last_name>
      <phone>214-345-4623</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 23, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Craig Crandall</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>laser treatment</keyword>
  <keyword>laser therapy</keyword>
  <keyword>skin blood flow</keyword>
  <keyword>sweating</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

